Timm8a2 Inhibitors
Timm8a2 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the Timm8a2 protein, a component of the mitochondrial import machinery involved in translocating proteins across the mitochondrial membrane. These inhibitors typically function by binding to key regions of the Timm8a2 protein, such as its substrate-binding site or other functional domains critical for its role in facilitating protein import. By occupying these essential regions, Timm8a2 inhibitors block the interaction between Timm8a2 and the precursor proteins it helps translocate, effectively disrupting its function in mitochondrial protein trafficking. In some cases, these inhibitors may also bind to allosteric sites located away from the active regions, inducing conformational changes that reduce the protein's activity. The interaction between Timm8a2 inhibitors and the protein is stabilized by non-covalent forces, such as hydrogen bonds, hydrophobic interactions, van der Waals forces, and electrostatic interactions, ensuring that the inhibitors remain tightly bound to the protein and effectively inhibit its activity.
Structurally, Timm8a2 inhibitors exhibit significant diversity, with a range of molecular designs tailored to interact precisely with different regions of the Timm8a2 protein. These inhibitors often incorporate functional groups such as hydroxyl, carboxyl, or amine groups, which facilitate hydrogen bonding and ionic interactions with key residues within the protein's binding sites. Additionally, aromatic rings and heterocyclic structures are frequently found in these inhibitors, enhancing hydrophobic interactions with non-polar regions of the protein and contributing to the stability of the inhibitor-protein complex. The physicochemical properties of Timm8a2 inhibitors, such as molecular weight, solubility, lipophilicity, and polarity, are carefully optimized to ensure they remain stable and effective in various biological environments. By balancing hydrophilic and hydrophobic regions, Timm8a2 inhibitors can selectively bind to both polar and non-polar areas of the protein, ensuring robust and efficient inhibition of Timm8a2 activity across a variety of cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may inhibit translocase of inner mitochondrial membrane 8A2 (TIMM8A2) expression by inhibiting RNA polymerase activity, thus preventing transcription of the TIMM8A2 gene and reducing its expression at the mRNA level. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide may inhibit translocase of inner mitochondrial membrane 8A2 (TIMM8A2) expression by inhibiting protein synthesis, which could lead to reduced translation of TIMM8A2 mRNA into protein, consequently lowering TIMM8A2 expression levels. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin may inhibit translocase of inner mitochondrial membrane 8A2 (TIMM8A2) expression by inhibiting RNA polymerase II activity, which could prevent transcription initiation of the TIMM8A2 gene, leading to reduced mRNA levels and subsequent decrease in TIMM8A2 protein expression. | ||||||
Azadirachtin | 11141-17-6 | sc-257105 sc-257105A sc-257105B sc-257105C sc-257105D | 1 mg 5 mg 10 mg 25 mg 50 mg | $177.00 $374.00 $626.00 $999.00 $1727.00 | ||
Azadirachtin may inhibit translocase of inner mitochondrial membrane 8A2 (TIMM8A2) expression by modulating transcription factors or coactivators involved in the regulation of TIMM8A2 gene expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin may inhibit translocase of inner mitochondrial membrane 8A2 (TIMM8A2) expression by inhibiting topoisomerase I activity, leading to DNA damage and activation of DNA damage response pathways, which could downregulate TIMM8A2 gene transcription and subsequently decrease TIMM8A2 expression. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Emetine may inhibit translocase of inner mitochondrial membrane 8A2 (TIMM8A2) expression by inhibiting protein synthesis, which could lead to reduced translation of TIMM8A2 mRNA into protein, consequently lowering TIMM8A2 expression levels. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil may inhibit translocase of inner mitochondrial membrane 8A2 (TIMM8A2) expression by interfering with nucleic acid synthesis, leading to DNA and RNA damage, which could trigger cellular responses that downregulate TIMM8A2 gene expression and reduce TIMM8A2 protein levels. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin may inhibit translocase of inner mitochondrial membrane 8A2 (TIMM8A2) expression by causing premature termination of protein synthesis, leading to reduced translation of TIMM8A2 mRNA into protein and consequent decrease in TIMM8A2 expression levels. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin may inhibit translocase of inner mitochondrial membrane 8A2 (TIMM8A2) expression by inhibiting bacterial RNA polymerase, which might indirectly affect TIMM8A2 expression by interfering with mitochondrial function or signaling pathways associated with TIMM8A2 regulation. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib may inhibit translocase of inner mitochondrial membrane 8A2 (TIMM8A2) expression by interfering with signaling pathways involved in cell proliferation and survival, which could indirectly affect TIMM8A2 expression levels through downstream regulatory mechanisms. | ||||||